Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination scheduleArticle Published on 2022-10-012022-11-15 Journal: Immunology letters [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] analyzed antibody Antibody testing ChAdOx1 vector vaccine circulating COVID-19 COVID-19 vaccination COVID-19 vaccine cross-reactive antibody detectable dose ENhance first dose Heterologous Heterologous COVID-19 vaccine schedule homologous humoral immune response IgG titer immune individual initial Initial non/low responder neutralization titer neutralizing antibody non-responder positive Retrospective study SARS-CoV-2 strain second dose Seroconversion Vaccination strategy vaccine dose vaccinee variants of concern [DOI] 10.1016/j.imlet.2022.09.001 PMC 바로가기
Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic reviewArticle Published on 2022-09-202022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료기술, [키워드] 95% CI Ad26 analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 vaccination antibodies antibody Antibody detection Antibody titer applied assays AstraZeneca convalescent individual correlation COVID-19 COVID-19 vaccines eligible ELISA assay evaluate flow cytometry highlight IgA IgG Immunity immunoassay Immunoglobulin immunological increasingly infected individuals janssen Johnson & Johnson lack moderate mRNA-based mucosal Neutralizing nine quantification reached reported Saliva salivary SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 detection selected serological test serum serum/plasma systematic review vaccinated individual vaccination Vaccination strategy Vaccine Web of Science [DOI] 10.3389/fimmu.2022.1006040 PMC 바로가기
Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipientsArticle Published on 2022-09-162022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] acute respiratory syndrome Administered adverse effect analyzed Anti-spike antibody BNT162b2 cellular cellular response Cellular responses ChAdOx1 Characteristics coronavirus creatinine Efficacy elicited first dose highest humoral immunogenicity interferon-γ kidney kidney transplant mRNA mRNA1273 Patient patients platform positive Protein Protein subunit recipient rejection renal function SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose the patient the spike protein vaccination Vaccination strategy Vaccine Vaccines Viral vector [DOI] 10.3389/fimmu.2022.951576 PMC 바로가기
Assessing COVID-19 vaccination strategies in varied demographics using an individual-based modelArticle Published on 2022-09-152022-11-15 Journal: Frontiers in Public Health [Category] SARS, 변종, 치료기술, 치료제, [키워드] age agent-based model (ABM) applied Assessing asymptomatic infections booster doses Characteristics Contact COVID COVID- 19 COVID-19 COVID-19 vaccination COVID-19 vaccine demographics distribution distributions Effectiveness Efficiency help Hospitalization household size individual individual-base model Infection infection rate Intervention New non-pharmaceutical interventions (NPIs) NPI NPIs outbreak parameter Prevent Probability reproductive responses against SARS-CoV-2 severe disease structures subpopulation symptomatic Total unique vaccinate vaccination Vaccination strategies Vaccination strategy variants variants of SARS-CoV-2 [DOI] 10.3389/fpubh.2022.966756 PMC 바로가기
Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in MexicoArticle Published on 2022-09-132022-11-16 Journal: Frontiers in Public Health [Category] SARS, 변종, [키워드] accumulated adverse outcome affected age Analysis analyzed caused children circulation country COVID-19 COVID-19 epidemic COVID-19 epidemic in Mexico COVID-19 hospitalization COVID-19 in children COVID-19 in pregnancy COVID-19 vaccination dataset death decrease Delta driven by dropped effective Effectiveness excess mortality. fatality health authorities hospitalizations individual Infant limit Mortality National omicron Omicron sub-lineages outbreak pediatric pregnant reduced retrospective cohort SARS-CoV-2 SARS-CoV-2 Delta VOC SARS-CoV-2 vaccine severe COVID-19 vaccination Vaccination strategy Vaccine Vaccines variants [DOI] 10.3389/fpubh.2022.1010256 PMC 바로가기
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialArticle Published on 2022-09-122022-11-15 Journal: Nature Communications [Category] SARS, 진단, [키워드] 1:1 age Analysis antibody blinded BNT162b2 booster vaccination cellular immune responses ChAdOx1 nCoV-19 clinical trial COVID-19 COVID-19 vaccination determine dose Endpoint EudraCT Heterologous homologous Immunosuppressed immunosuppressed patients Impaired include mRNA mRNA vaccination mRNA vaccine mRNA-1273 multivariable logistic regression outcome Patient performed Randomized Randomized controlled trial receive reduced SARS-CoV-2 spike SARS-CoV-2-specific T-cell response secondary Serious Adverse Event Seroconversion seroconversion rate seroconvert significantly higher single center Support vaccination Vaccination strategy Vaccine vaccine group [DOI] 10.1038/s41467-022-33036-y PMC 바로가기
Assessment of humoral immune response to two mRNA SARS-CoV-2 vaccines (Moderna and Pfizer) in healthcare workers fully vaccinated with and without a history of previous infectionArticle Published on 2022-09-012022-11-15 Journal: Journal of Applied Microbiology [Category] COVID19(2023년), SARS, 진단, [키워드] Abbott analysed Analysis anti-S IgG anti-S IgG SARS-CoV-2 anti-SARS-CoV-2 vaccines antibody assessment BNT162b2 contribute decrease eight healthcare healthcare worker Healthcare workers humoral immune response IgG IgG response immune immune response Immune status in both group Infection knowledge mean value Moderna mRNA mRNA SARS-CoV-2 vaccines mRNA-1273 Patient persist Pfizer positive post-vaccination. Presence revaccination RIPOVAC SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccine Significance significantly higher Spain System vaccination Vaccination strategy Vaccine was performed [DOI] 10.1111/jam.15699 PMC 바로가기
Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantationArticle Published on 2022-09-012022-11-15 Journal: The Journal of heart and lung transplantation : th [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] Anti-RBD antibody anti-RBD IgG antibody Antibody Response BNT162b2 BNT162b2 vaccine cellular immunity changes in Delta variants demonstrated detectable domain dose Efficacy Efficiency elicit fourth dose group Heart transplantation high-risk population IgG immune responses Immunological response IMPROVE Infection investigated long-lasting majority neutralization neutralizing antibody neutralizing responses omicron Omicron variant preventive measure recipients vaccination Vaccination strategy variant variants of concern wild-type virus [DOI] 10.1016/j.healun.2022.04.014 PMC 바로가기
Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysisResearch article Published on 2022-09-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] 변종, [키워드] 95% confidence interval advanced age anti-CD20 therapy article Cancer Cancer patients cancer treatment Chemotherapy China cohort study Complete Concentration correlated Course COVID-19 vaccination COVID-19 vaccine database Endocrine Factor heterogeneity Immunotherapy inclusion criteria Infrastructure item male Meta-analysis metastatic disease Mutation no significant difference Odds ratio outcome Patient patients Patients with cancer predict predictor predictors Probability receiving Registered Relating reported Reporting Result review searched Seroconversion Serologic response statistical systematic review Treatment vaccination Vaccination strategy was used [DOI] 10.1016/j.ejca.2022.05.031 [Article Type] Research article
COVID-19 vaccination, incidence, and mortality rates among indigenous populations compared to the general population in Brazil: Describing trends over timeResearch article Published on 2022-09-012022-10-05 Journal: The Lancet Regional Health - Americas [Category] 진단, [키워드] absence Adults age available data Brazil chronic Coverage COVID-19 COVID-19 incidence COVID-19 pandemic COVID-19 vaccination cumulative cumulative mortality death decrease Describing detrimental Effectiveness extreme finding funding General population health inequities Health inequity heterogeneity implementation incidence incidence rate incidence rates Indigenous populations information Isolation Ministry of Health Mortality mortality rate Older Population populations regions reported resource respond supported the vaccine Trends over time vaccination Vaccination strategy Vaccine [DOI] 10.1016/j.lana.2022.100319 [Article Type] Research article